Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM-CP: Melatonin for sleep disturbance in chronic pain
2018-004048-50Phase 2Unknown
- Sponsor
- University of Aberdeen
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sleep disorder comparing Circadin (melatonin) with Placebo (2 arms). Primary endpoint: Primary: Sleep disturbance. Status: unknown.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2018-004048-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004048-50.